Cerebrovascular Disorders  >>  Cerebrolysin (porcine brain-derived proteolytic peptide fraction)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cerebrolysin (porcine brain-derived proteolytic peptide fraction) / Novartis, EVER Pharma
CerebroHIE, NCT01059461: Study of Cerebrolysin for Treatment of Infants With History of Neonatal Hypoxic Ischemic Encephalopathy

Completed
2
40
RoW
Cerebrolysin®, Nerve Growth Factor
Sahar M.A. Hassanein, MD
Hypoxic-Ischemic Encephalopathy
09/13
09/13

Download Options